Trials Offered by a Specific Doctor

Marcus Pereira, MD, MPH

Dr. Marcus Pereira is an Assistant Clinical Professor of Medicine at the Columbia University College of Physicians. During fellowship at Columbia University, he studied the prevalence and risk factors for chronic kidney disease among patients in our HIV clinic. He also joined Dr. Fidock's laboratory to study malaria drug resistance and in vivo PK/PD trials of antimalarial drug combinations. Spearheading the Transplant Infectious Diseases Program, Dr. Pereira is focused on infectious complications among transplant patients in both inpatient and outpatient settings. He is also involved in the development of infection prophylaxis and treatment protocols in immunocompromised patients. His current research includes multi-drug resistant infections, including bacterial and fungal organisms among renal and liver transplant patients as well as resistant CMV infections

Clinical Studies Managed By Dr. Pereira:
More InfoTitleSponsorIRB Number
DetailsEffectiveness and safety of Maribavir in transplant recipients with Cytomegalovirus (CMV) Infections that are resistant to treatmentShireAAAR0147
DetailsStudy of MK-8228 (Letermovir) vs. Valganciclovir for Prevention of CMV Disease in Adult Kidney Transplant RecipientsMerck Sharpe & Dohme Corp.AAAR7454
DetailsHOPE in Action: Trial of HIV+ Deceased Donor Kidney Transplants for HIV+ RecipientsThe National Institute of Allergy and Infectious Diseases NIAIDAAAR7423
DetailsA Study of HIV+ Deceased Donor Liver Transplants for HIV+ Recipients (Liver Transplant)NIAIDAAAS2561
DetailsA Study of HIV+ Deceased Donor Liver Transplants for HIV+ Recipients (HIV)NIAIDAAAS2561
Details[CLOSED] Study of the Hologic Cytomegalovirus (CMV) AssayHologic, Inc.AAAS4633